Concepedia
Statistics
Publications
70
Citations
7K
H-Index
43
Active since
1999
Affiliations
Johnson & Johnson (United States)(Current)
Janssen (Belgium)
Janssen (United States)
Johnson & Johnson (Sweden)
Bar-Ilan University
Mariëlle Eerdekens is an author at Johnson & Johnson (United States) specializing in medicine, psychiatry, and pharmacotherapy.
Top concepts
MedicinePsychiatryPharmacotherapyPsychopharmacologyPharmacologySchizophreniaPsychopathologySocial SciencesNeuropharmacologyAddiction
Publications per year
1999–2023
Long-Acting Injectable Risperidone: Efficacy and Safety of the First Long-Acting Atypical Antipsychotic
John M. Kane, Mariëlle Eerdekens, Jean‐Pierre Lindenmayer et al. · American Journal of Psychiatry · 2003 · 474 citations
Risperidone and Haloperidol in First-Episode Psychosis: A Long-Term Randomized Trial
Nina R. Schooler, Jonathan Rabinowitz, Michael Davidson et al. · American Journal of Psychiatry · 2005 · 345 citations
Treatment of Schizophrenia With Long-Acting Injectable Risperidone
W. Wolfgang Fleischhacker, Mariëlle Eerdekens, Keith Karcher et al. · The Journal of Clinical Psychiatry · 2003 · 287 citations
Treatment of schizophrenia with paliperidone extended-release tablets: A 6-week placebo-controlled trial☆
John M. Kane, F. Cañas, Michelle Kramer et al. · Schizophrenia Research · 2006 · 281 citations
Psychiatry, Psychotic Disorder, Psychotropic Medication +7
Rapid Antimanic Effect of Risperidone Monotherapy: A 3-Week Multicenter, Double-Blind, Placebo-Controlled Trial
Robert M. A. Hirschfeld, Paul E. Keck, Michelle Kramer et al. · American Journal of Psychiatry · 2004 · 258 citations
1–5 of 70